Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.





PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics

APA-OTS-Meldungen aus dem Finanzsektor in der "BSN Extended Version"
Wichtige Originaltextaussendungen aus der Branche. Wir ergänzen vollautomatisch Bilder aus dem Fundus von photaq.com und Aktieninformationen aus dem Börse Social Network. Wer eine Korrektur zu den Beiträgen wünscht: mailto:office@boerse-social.com . Wir wiederum übernehmen keinerlei Haftung für Augenerkrankungen aufgrund von geballtem Grossbuchstabeneinsatz der Aussender. Wir meinen: Firmennamen, die länger als drei Buchstaben sind, schreibt man nicht durchgängig in Grossbuchstaben (Versalien).


10.08.2020
Tokyo and Basel, Switzerland (ots/PRNewswire) - PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. The partnership comprises a global commercialization and distribution agreement and a concurrent financing agreement.
As part of the commercialization and distribution agreement, Ascensia has been appointed the exclusive global distribution partner for Senseonics' CGM systems, including Eversense®, Eversense® XL and future generation products in development, such as the 365-day implantable sensor. In the U.S., Ascensia will initiate marketing and sales activities of the Eversense product in the coming months, in collaboration with Senseonics, and will take over full responsibility in the first quarter of 2021. In Europe, Ascensia will begin commercialization activities in selected countries once Senseonics' existing distribution relationships have concluded.
Under the terms of the agreement, the exclusive distribution rights to Senseonics' products are expected to last through 2025, with the exact timing dependent on factors including the launch dates for certain future generation products.
As part of the financing agreement, PHC Holdings Corporation, the parent company of Ascensia, has made an initial strategic investment of USD $35 million into Senseonics in the form of convertible debt securities. In addition, a further USD $15 million investment will be provided in exchange for Senseonics convertible preferred equity, upon FDA approval of the 180-day Eversense product.
"We are thrilled to be entering into this partnership with Senseonics and strongly believe in the value of the Eversense technology. They have highly accurate and effective products on the market and a strong pipeline of innovative solutions that can address the needs of people with diabetes. We are excited by their future generation products, particularly the 365-day sensor, which we think has the potential to simplify diabetes management and improve lives," explained Robert Schumm, President of Ascensia Diabetes Care and Diabetes Management Domain Head, PHC Group.
He added, "This partnership is the next step in building a world-class diabetes care franchise for Ascensia, as we look to expand our business beyond blood glucose monitoring. It will enable us to establish a presence in the CGM market, especially in the U.S. and Europe, and will further strengthen our existing portfolio of products. We believe that the combination of our commercial expertise and infrastructure, alongside Senseonics' product development and clinical expertise, will help to get the Eversense and Eversense XL products into the hands of people with diabetes who can benefit from them. Our aim is to work together to bring these highly effective technologies to more people with diabetes, therefore providing further choice in CGM for diabetes management. We look forward to launching the 180-day Eversense product in the U.S. and a long and successful relationship with Senseonics."
"We are extremely excited to be partnering with Ascensia, a global leader in the diabetes technology space. Ascensia is well known for their high-quality CONTOUR products used by more than 10 million patients worldwide to help manage their diabetes," said Tim Goodnow, PhD, President and CEO of Senseonics. "Their global commercial infrastructure and commitment to the Eversense systems will drive market penetration, while allowing Senseonics to focus on further development of our implanted technology."
Photo: https://mma.prnewswire.com/media/1226338/Eversense_CGM.jp...
Logo: https://mma.prnewswire.com/media/749389/Ascensia_Diabetes... pg
Digital press kit: http://www.ots.at/pressemappe/PR147142/aom


 

Aktien auf dem Radar:Mayr-Melnhof, Kapsch TrafficCom, Marinomed Biotech, UBM, FACC, Warimpex, Zumtobel, Wienerberger, AMS, DO&CO, Erste Group, Immofinanz, Lenzing, SBO, S Immo, OMV, RBI, ATX, ATX Prime, Andritz, AT&S, Bawag, CA Immo, Flughafen Wien, voestalpine, Porr, LINDE, Deutsche Telekom, Allianz, Beiersdorf, E.ON .


Random Partner

Agrana
Die Agrana Beteiligungs-AG ist ein Nahrungsmittel-Konzern mit Sitz in Wien. Agrana erzeugt Zucker, Stärke, sogenannte Fruchtzubereitungen und Fruchtsaftkonzentrate sowie Bioethanol. Das Unternehmen veredelt landwirtschaftliche Rohstoffe zu vielseitigen industriellen Produkten und beliefert sowohl lokale Produzenten als auch internationale Konzerne, speziell die Nahrungsmittelindustrie.

>> Besuchen Sie 56 weitere Partner auf boerse-social.com/partner


Mehr aktuelle OTS-Meldungen HIER

Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten


Ausgewählte Events von BSN-Partnern


Meistgelesen
>> mehr





Newsflow
>> mehr

Börse Social Club Board
>> mehr
    Börse Social Depot Trading Kommentar (Depot Kommentar)
    Heute und morgen grosse Zertifikate Tage in Wien, heute kann man live dabei sein
    Star der Stunde: UBM 2.48%, Rutsch der Stunde: FACC -1.13%
    wikifolio-Trades Austro-Aktien 12-13: OMV(1), Porr(1), Österreichische Post(1), Immofinanz(1)
    Star der Stunde: Semperit 1.44%, Rutsch der Stunde: Porr -0.9%
    wikifolio-Trades Austro-Aktien 11-12: S&T(2), Immofinanz(1), Strabag(1), Fabasoft(1)
    Star der Stunde: FACC 3.6%, Rutsch der Stunde: Semperit -1.54%
    wikifolio-Trades Austro-Aktien 10-11: Fabasoft(7), Verbund(2), Kapsch TrafficCom(1), OMV(1), Strabag(1), Lenzing(1), DO&CO(1), Porr(1)
    Unser Robot findet: Deutsche Telekom, Allianz, Beiersdorf, E.ON und 22 weitere auffällig

    Featured Partner Video

    AUSTRIAN STOCK TALK: Vienna Insurance Group AG (2020) Deutsch

    Austrian Stock Talk by Wiener Börse: Kompakte Informationen für Investoren und die, die es noch werden wollen. Jetzt unseren Youtube-Kanal abonnieren! CEO der Vienna Insurance Group AG El...

    PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics


    10.08.2020
    Tokyo and Basel, Switzerland (ots/PRNewswire) - PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. The partnership comprises a global commercialization and distribution agreement and a concurrent financing agreement.
    As part of the commercialization and distribution agreement, Ascensia has been appointed the exclusive global distribution partner for Senseonics' CGM systems, including Eversense®, Eversense® XL and future generation products in development, such as the 365-day implantable sensor. In the U.S., Ascensia will initiate marketing and sales activities of the Eversense product in the coming months, in collaboration with Senseonics, and will take over full responsibility in the first quarter of 2021. In Europe, Ascensia will begin commercialization activities in selected countries once Senseonics' existing distribution relationships have concluded.
    Under the terms of the agreement, the exclusive distribution rights to Senseonics' products are expected to last through 2025, with the exact timing dependent on factors including the launch dates for certain future generation products.
    As part of the financing agreement, PHC Holdings Corporation, the parent company of Ascensia, has made an initial strategic investment of USD $35 million into Senseonics in the form of convertible debt securities. In addition, a further USD $15 million investment will be provided in exchange for Senseonics convertible preferred equity, upon FDA approval of the 180-day Eversense product.
    "We are thrilled to be entering into this partnership with Senseonics and strongly believe in the value of the Eversense technology. They have highly accurate and effective products on the market and a strong pipeline of innovative solutions that can address the needs of people with diabetes. We are excited by their future generation products, particularly the 365-day sensor, which we think has the potential to simplify diabetes management and improve lives," explained Robert Schumm, President of Ascensia Diabetes Care and Diabetes Management Domain Head, PHC Group.
    He added, "This partnership is the next step in building a world-class diabetes care franchise for Ascensia, as we look to expand our business beyond blood glucose monitoring. It will enable us to establish a presence in the CGM market, especially in the U.S. and Europe, and will further strengthen our existing portfolio of products. We believe that the combination of our commercial expertise and infrastructure, alongside Senseonics' product development and clinical expertise, will help to get the Eversense and Eversense XL products into the hands of people with diabetes who can benefit from them. Our aim is to work together to bring these highly effective technologies to more people with diabetes, therefore providing further choice in CGM for diabetes management. We look forward to launching the 180-day Eversense product in the U.S. and a long and successful relationship with Senseonics."
    "We are extremely excited to be partnering with Ascensia, a global leader in the diabetes technology space. Ascensia is well known for their high-quality CONTOUR products used by more than 10 million patients worldwide to help manage their diabetes," said Tim Goodnow, PhD, President and CEO of Senseonics. "Their global commercial infrastructure and commitment to the Eversense systems will drive market penetration, while allowing Senseonics to focus on further development of our implanted technology."
    Photo: https://mma.prnewswire.com/media/1226338/Eversense_CGM.jp...
    Logo: https://mma.prnewswire.com/media/749389/Ascensia_Diabetes... pg
    Digital press kit: http://www.ots.at/pressemappe/PR147142/aom


     

    Aktien auf dem Radar:Mayr-Melnhof, Kapsch TrafficCom, Marinomed Biotech, UBM, FACC, Warimpex, Zumtobel, Wienerberger, AMS, DO&CO, Erste Group, Immofinanz, Lenzing, SBO, S Immo, OMV, RBI, ATX, ATX Prime, Andritz, AT&S, Bawag, CA Immo, Flughafen Wien, voestalpine, Porr, LINDE, Deutsche Telekom, Allianz, Beiersdorf, E.ON .


    Random Partner

    Agrana
    Die Agrana Beteiligungs-AG ist ein Nahrungsmittel-Konzern mit Sitz in Wien. Agrana erzeugt Zucker, Stärke, sogenannte Fruchtzubereitungen und Fruchtsaftkonzentrate sowie Bioethanol. Das Unternehmen veredelt landwirtschaftliche Rohstoffe zu vielseitigen industriellen Produkten und beliefert sowohl lokale Produzenten als auch internationale Konzerne, speziell die Nahrungsmittelindustrie.

    >> Besuchen Sie 56 weitere Partner auf boerse-social.com/partner


    Mehr aktuelle OTS-Meldungen HIER

    Useletter

    Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

    Newsletter abonnieren

    Runplugged

    Infos über neue Financial Literacy Audio Files für die Runplugged App
    (kostenfrei downloaden über http://runplugged.com/spreadit)

    per Newsletter erhalten


    Ausgewählte Events von BSN-Partnern


    Meistgelesen
    >> mehr





    Newsflow
    >> mehr

    Börse Social Club Board
    >> mehr
      Börse Social Depot Trading Kommentar (Depot Kommentar)
      Heute und morgen grosse Zertifikate Tage in Wien, heute kann man live dabei sein
      Star der Stunde: UBM 2.48%, Rutsch der Stunde: FACC -1.13%
      wikifolio-Trades Austro-Aktien 12-13: OMV(1), Porr(1), Österreichische Post(1), Immofinanz(1)
      Star der Stunde: Semperit 1.44%, Rutsch der Stunde: Porr -0.9%
      wikifolio-Trades Austro-Aktien 11-12: S&T(2), Immofinanz(1), Strabag(1), Fabasoft(1)
      Star der Stunde: FACC 3.6%, Rutsch der Stunde: Semperit -1.54%
      wikifolio-Trades Austro-Aktien 10-11: Fabasoft(7), Verbund(2), Kapsch TrafficCom(1), OMV(1), Strabag(1), Lenzing(1), DO&CO(1), Porr(1)
      Unser Robot findet: Deutsche Telekom, Allianz, Beiersdorf, E.ON und 22 weitere auffällig

      Featured Partner Video

      AUSTRIAN STOCK TALK: Vienna Insurance Group AG (2020) Deutsch

      Austrian Stock Talk by Wiener Börse: Kompakte Informationen für Investoren und die, die es noch werden wollen. Jetzt unseren Youtube-Kanal abonnieren! CEO der Vienna Insurance Group AG El...